Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Winlevi + Duac in Acne Vulgaris
NCT06336629Phase 4Completed
- Sponsor
- Sun Pharma
- Start
- Nov 2023
- Primary completion
- Jul 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of clascoterone in acne vulgaris, sponsored by Sun Pharma. Started Nov 2023; status: completed.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT06336629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06336629.